Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited

Authors

  • Elisa Ríos-Viñuela Department of Dermatology, Instituto Valenciano de Oncología, ES-46009 Valencia, Spain
  • Eduardo Bernia
  • Tomás Toledo-Pastrana
  • Celia Requena
  • Adrián Diago
  • Carlos Serra-Guillén
  • Beatriz Llombart
  • Victor Traves
  • Eduardo Nagore
  • Carlos Guillén
  • Onofre Sanmartin

DOI:

https://doi.org/10.2340/00015555-3791

Keywords:

toxic erythema of chemotherapy, localized epidermal necrolysis, cytostatic drugs, chemotherapy adverse effect, chemotherapy skin eruption, drug reaction

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol 2008; 59: 524-529.

DOI: https://doi.org/10.1016/j.jaad.2008.05.018

Reyes-Habito CM, Roh EK. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: Part II. Targeted therapy. J Am Acad Dermatol 2014; 71: 217.e1-217.e11.

DOI: https://doi.org/10.1016/j.jaad.2014.04.013

Sanmartin O, Beato C, Suh-Oh HJ, Aragon I, Espana A, Majem M, et al. Clinical management of cutaneous adverse events in patients on chemotherapy: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology. Actas Dermosifiliogr 2019; 110: 448-459.

DOI: https://doi.org/10.1016/j.adengl.2019.05.003

Sibaud V, Fricain JC, Baran R, Robert C. Pigmentary disorders induced by anticancer agents. Part I: Chemotherapy. Ann Dermatol Venereol 2013; 140: 183-196.

DOI: https://doi.org/10.1016/j.annder.2012.12.012

Sibaud V. Toxic erythema of chemotherapy. Ann Dermatol Venereol 2015; 142: 81-84.

DOI: https://doi.org/10.1016/j.annder.2014.09.021

Reynolds PM, MacLaren R, Mueller SW, Fish DN, Kiser TH. Management of extravasation injuries: a focused evaluation of noncytotoxic medications. Pharmacotherapy 2014; 34: 617-632.

DOI: https://doi.org/10.1002/phar.1396

Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. Am J Surg 1979; 137: 497-506.

DOI: https://doi.org/10.1016/0002-9610(79)90121-1

Arias D, Requena L, Hasson A, Gutierrez M, Domine M, Martin L, et al. Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine. J Cutan Pathol 1991; 18: 344-346.

DOI: https://doi.org/10.1111/j.1600-0560.1991.tb01547.x

Chew L, Chuen VSL. Cutaneous reaction associated with weekly docetaxel administration. J Oncol Pharm Pract 2009; 15: 29-34.

DOI: https://doi.org/10.1177/1078155208096111

Chu CY, Yang CH, Yang CY, Hsiao GH, Chiu HC. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel. Br J Dermatol 2000; 142: 808-811.

DOI: https://doi.org/10.1046/j.1365-2133.2000.03432.x

Geddes ERC, Cohen PR. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy. South Med J 2010; 103: 231-235.

DOI: https://doi.org/10.1097/SMJ.0b013e3181ce0f5e

Ghosh SK, Bandyopadhyay D, Ghoshal L, Basu S. Letter: docetaxel-induced supravenous serpentine dermatitis. Dermatol Online J 2011; 17: 16.

Marcoux D, Anex R, Russo P. Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine. J Am Acad Dermatol 2000; 43: 540-546.

DOI: https://doi.org/10.1067/mjd.2000.106239

Lang K, Groeger M, Neumann NJ, Ruzicka T, Fritsch C. Supravenous hyperpigmentation, transverse leuconychia and transverse melanonychia after chemotherapy for Hodgkin's disease. J Eur Acad Dermatol Venereol 2002; 16: 162-163.

DOI: https://doi.org/10.1046/j.1468-3083.2002.00424.x

Chan C-C, Lin S-J. Images in clinical medicine. Serpentine supravenous hyperpigmentation. N Engl J Med 2010; 363: e8.

DOI: https://doi.org/10.1056/NEJMicm0911228

Downloads

Additional Files

Published

2021-04-12

How to Cite

Ríos-Viñuela, E., Bernia, E., Toledo-Pastrana, T., Requena, C., Diago, . A., Serra-Guillén, C., Llombart, B., Traves, V., Nagore, E., Guillén, C., & Sanmartin, O. (2021). Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited. Acta Dermato-Venereologica, 101(4), adv00429. https://doi.org/10.2340/00015555-3791

Issue

Vol. 101 No. 4 (2021): April

Section

Short Communication

Categories

License

Copyright (c) 2021 Elisa Ríos-Viñuela, Eduardo Bernia, Tomás Toledo-Pastrana, Celia Requena, Adrián Diago, Carlos Serra-Guillén, Beatriz Llombart, Victor Traves, Eduardo Nagore, Carlos Guillén, Onofre Sanmartin

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC